Prytime Medical Devices Receives Key Approval for European Market

Prytime Medical Devices , a Boerne-based, privately-held medical technology company that develops minimally invasive solutions for treating trauma, announced Tuesday that it has received CE CERTIFICATION approval for the company’s ER-REBOA Catheter and has begun preparation for a targeted market release in Europe.

“Simply put, no one should bleed to death, and the sooner you stop bleeding the better,” CEO of Prytime Medical Devices David Spencer stated. “CE Mark approval enables us to accelerate our expansion outside the U.S. while providing European clinicians an exciting new tool to temporarily stop bleeding and save lives.”

CE Marking is an unfamiliar term to most in the U.S. market, but in the European Economic Area (EEA) it signifies a product’s approval for sale across the 28-nation market.